Caring Brands Closes $2.55M Series B Tranche, Pro Forma Equity Hits $8.2M
CABR sits 61% above its 52-week low of $0.71 on light trading volume (0.2× avg).
Summary
Caring Brands closed a $2.55 million second tranche of its Series B Preferred financing, bringing total proceeds to $7.15 million. Pro forma stockholders' equity now stands at $8.22 million, exceeding Nasdaq's $2.5 million minimum and supporting the company's appeal against delisting.
Key Events · Financing and Capital Events · CABR
-
Second Series B Closing Completed
Issued 2,549.9 shares of Series B Preferred Stock plus 2,549,900 Series A Warrants and 2,549,900 Series B Warrants for gross proceeds of $2,549,900. Total offering proceeds now $7,149,900.
-
Pro Forma Equity Exceeds Nasdaq Minimum
Preliminary pro forma stockholders' equity of $8,220,419 as of August 31, 2026, versus Nasdaq's $2,500,000 requirement — a cushion of $5,720,419.
-
Series A Reclassified to Permanent Equity
$3,852,686 of Series A Convertible Redeemable Preferred Stock moved from mezzanine to permanent equity after holders waived redemption rights, eliminating a $4.2M redemption overhang.
-
Nasdaq Compliance Requested
Company believes it has regained compliance with Listing Rule 5550(b)(1) and has asked the Nasdaq Hearings Panel to confirm. No assurance the Panel will agree.
Analysis · CABR · Industrial Applications And Services
A second closing of the Series B Preferred financing brought in $2.55 million, lifting total gross proceeds to $7.15 million. The filing also includes a preliminary pro forma balance sheet showing stockholders' equity of $8.22 million — well above Nasdaq's $2.5 million minimum — after reclassifying $3.85 million of Series A Preferred from mezzanine to permanent equity. This directly addresses the company's delisting fight: management believes it has regained compliance with the equity requirement and has asked the Nasdaq Hearings Panel to confirm. The stock trades at $1.14 with a market cap of only $11.8 million, so this financing is highly dilutive but also critical for survival. The Series B warrants carry exercise prices of $0.825 and $0.95, below the current share price, creating additional overhang.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 35.8% of the 1706 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.10%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CABR was trading at $1.14 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $11.8M. The 52-week trading range was $0.71 to $6.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.